P1036a (DAIDS ID 10193): Directly Observed Therapy in HIV-Infected Adolescents: Part A - Focus Groups

Study Status Study Restriction

Concluded

United States

What is P1036a?

P1036a was a focus group to inform the Directly Observed Therapy (DOT) intervention model.  The study was designed to obtain information for a DOT intervention model that will be accepted by adolescents and was used to inform P1036b.

Study documents:

Sites where the study is implemented:

CRS ID Site Name City Country

4201

University of Miami Pediatric/Perinatal HIV/AIDS

Miami

United States of America

5048

University of Southern California LA

Los Angeles

United States of America

6501

St. Jude/UTHSC CRS

Memphis

United States of America

Study contacts:

Study Chair: Patricia Flynn

Study Vice-Chair: Marvin Belzer

Investigator: Aditya Gaur

Investigator: George McSherry

Laboratory Technologist: William Kabat

Medical Officer: Audrey Rogers

Neuropsychologist: Patricia Garvie

Pharmacologist: Francesca Aweeka

Pharmacologist: Lynette Purdue

Statistician: Hu Chengcheng

Virologist: Stephen Spector

CTS: IMPAACT.OperationsCenter@fstrf.org

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.